Hemab Therapeutics Holdings Inc（COAG）價格預測

$44.020

-1.646 (-3.74%)收盤時

價格預測

1-Day Price Prediction

+2.77%

1-Week Prediction

+4.82%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

在 App 中開啟以解鎖更長週期的預測。

Loading chart…

COAG 相似圖表分析預測

Alphio's COAG stock price prediction model matches the current Hemab Therapeutics Holdings Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $45.24 (+2.77%). The 1-week path is $46.14 (+4.82%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

該買進 Hemab Therapeutics Holdings Inc 股票嗎？

Currently, Hemab Therapeutics (COAG) is trading at $44.84, significantly below the average analyst price target of $60, indicating potential upside. However, the stock has a low RSI of 29.128, suggesting it is oversold, but it also reported a wider Q2 loss of $24.2 million, which raises concerns about its financial health. Therefore, while there is potential for recovery, the current financial losses and market volatility suggest a cautious approach.